Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Journal Article (Journal Article)

Pulmonary arterial hypertension (PAH) occurs as an idiopathic process or as a component of a variety of disease processes, including chronic thromboembolic disease, connective tissue diseases, congenital heart disease, and exposure to exogenous factors including appetite suppressants or infectious agents such as HIV. This article reviews evidence for screening in susceptible patient groups and the approach to diagnosing PAH when it is suspected, and provides specific recommendations for applying this evidence to clinical practice.

Full Text

Duke Authors

Cited Authors

  • McGoon, M; Gutterman, D; Steen, V; Barst, R; McCrory, DC; Fortin, TA; Loyd, JE; American College of Chest Physicians,

Published Date

  • July 1, 2004

Published In

Volume / Issue

  • 126 / 1 Suppl

Start / End Page

  • 14S - 34S

PubMed ID

  • 15249493

International Standard Serial Number (ISSN)

  • 0012-3692

Digital Object Identifier (DOI)

  • 10.1378/chest.126.1_suppl.14S


  • eng

Conference Location

  • United States